Bulsara Ketan R, McGirt Matthew J, Liao Lawrence, Villavicencio Alan T, Borel Cecil, Alexander Michael J, Friedman Allan H
Department of Surgery Neurosurgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Neurosurg. 2003 Mar;98(3):524-8. doi: 10.3171/jns.2003.98.3.0524.
Differentiating myocardial infarction (MI) from reversible neurogenic left ventricular dysfunction (stunned myocardium [SM]) associated with aneurysmal subarachnoid hemorrhage (SAH) is critical for early surgical intervention. The authors hypothesized that the cardiac troponin (cTn) trend and/or echocardiogram could be used to differentiate between the two entities.
A retrospective study was conducted for the period between 1995 and 2000. All patients included in the study met the following criteria: 1) no history of cardiac problems; 2) new onset of abnormal cardiac function (ejection fraction [EF] < 40% on echocardiograms); 3) serial cardiac markers (cTn and creatine kinase MB isoform [CK-MB]); 4) surgical intervention for their aneurysm; and 5) cardiac output monitoring either by repeated echocardiograms or invasive hemodynamic monitoring during the first 4 days post-SAH when the patients were euvolemic. Of the 350 patients with SAH, 10 (2.9%) had severe cardiac dysfunction. Of those 10, six were women and four were men. The patients' mean age was 53.5 years (range 29-75 years) and their SAH was classified as Hunt and Hess Grade III or IV. Aneurysm distribution was as follows: basilar artery tip (four); anterior communicating artery (two); middle cerebral artery (one); posterior communicating artery (two); and posterior inferior cerebellar artery (one). The mean EFonset was 33%. The changes on echocardiograms in these patients did not match the findings on electrocardiograms (EKGs). Within 4.5 days, dramatic improvement was seen in cardiac output (from 4.93 +/- 1.16 L/minute to 7.74 +/- 0.88 L/minute). Compared with historical controls in whom there were similar levels of left ventricular dysfunction after MI, there was no difference in peak CK-MB. A 10-fold difference, however, was noted in cTn values (0.22 +/- 0.25 ng/ml; control 2.8 ng/ml; p < 0.001).
The authors determined the following: 1) that the CK-MB trend does not allow differentiation between SM and MI; 2) that echocardiograms revealing significant inconsistencies with EKGs are indicative of SM; and 3) that cTn values less than 2.8 ng/ml in patients with EFs less than 40% are consistent with SM.
区分心肌梗死(MI)与蛛网膜下腔出血(SAH)合并动脉瘤时可逆性神经源性左心室功能障碍(心肌顿抑[SM])对于早期手术干预至关重要。作者推测心肌肌钙蛋白(cTn)变化趋势和/或超声心动图可用于区分这两种情况。
对1995年至2000年期间进行了一项回顾性研究。纳入研究的所有患者均符合以下标准:1)无心脏问题病史;2)新出现心脏功能异常(超声心动图显示射血分数[EF]<40%);3)系列心脏标志物(cTn和肌酸激酶同工酶MB[CK-MB]);4)对其动脉瘤进行手术干预;5)在SAH后最初4天内当患者血容量正常时通过重复超声心动图或有创血流动力学监测进行心输出量监测。在350例SAH患者中,10例(2.9%)出现严重心脏功能障碍。在这10例患者中,6例为女性,4例为男性。患者平均年龄为53.5岁(范围29 - 75岁),其SAH分级为Hunt和HessⅢ级或Ⅳ级。动脉瘤分布如下:基底动脉尖部(4例);前交通动脉(2例);大脑中动脉(1例);后交通动脉(2例);小脑后下动脉(1例)。平均起病时EF为33%。这些患者超声心动图的变化与心电图(EKG)结果不相符。在4.5天内,心输出量显著改善(从4.93±1.16升/分钟增至7.74±0.88升/分钟)。与MI后左心室功能障碍程度相似的历史对照相比,CK-MB峰值无差异。然而,cTn值存在10倍差异(0.22±0.25纳克/毫升;对照2.8纳克/毫升;p<0.001)。
作者确定了以下几点:1)CK-MB变化趋势无法区分SM和MI;2)超声心动图显示与EKG存在显著不一致提示为SM;3)EF<40%的患者cTn值小于2.8纳克/毫升与SM相符。